Global Blood Irradiation Market –
Regional Insights
Based on the region, the global Blood
Irradiation Market is segmented into North America, Europe, Latin America,
Asia Pacific, Middle East, and Africa. North America accounted for the dominant
position in the blood irradiation market, owing to growing awareness among the
population regarding blood related diseases and launch of new innovative
technology in the field of healthcare.
For instance, in 2017, Typenex
Medical launched Rad-Control, a new irradiation indicator tag technology for
blood centers and blood banks in Canada and the U.S. This checks blood
irradiation by visual verification, minimizes current documentation practices,
and increases efficiency for healthcare staff.
Asia Pacific is expected to show
significant growth in the global blood irradiation market followed by Europe.
Rising population vulnerable to various chronic diseases and government
involvement in maintaining safety standards for new product launches is
expected to propel the blood irradiation market growth in the region. For
instance, in 2015, UVLrx Therapeutics received CE Marking (European Conformity)
for its intravenous UV light therapy device, that offers intravenous,
concurrent delivery of ultraviolet-A (UVA), and multiple visible light
wavelengths.
Blood irradiation is a therapy in
which blood components are irradiated prior to transfusion, to prevent
proliferation of certain types of T lymphocytes. These T lymphocytes inhibit
the immune responses and can cause a rare graft-versus-host disease (GVHD) with
serious complication due to blood transfusion caused by white blood cells. A
small number of white blood cells can recognize the different blood in the body
which may cause serious illness or death.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1939
Irradiated blood is treated with
UV, X-rays or other forms of radioactive methods. Blood irradiation treated with
UV rays is beneficial to cancer patients as it strengthens the immune system
and improves overall health.
Ultraviolet rays restrain viral,
bacterial, and fungal growth and improves the body’s ability to detoxify and
inactive toxins, which can further assist in the other cancer treatments. Based
on this technique, three types of blood irradiation are available in the market
i.e. intravenous laser blood irradiation, transcutaneous laser blood
irradiation, and extracorporeal blood irradiation.
Global Blood Irradiation Market
Dynamics
Increasing global population
vulnerable to various communicable and non-communicable diseases (NCD’s) such
as cancer, chronic kidney disease, high blood pressure disease, stroke and
cardiovascular diseases, which is expected to drive the global blood
irradiation market growth. For instance, according to the World Bank’s 2016
report, the global population reached up to 7.44 billion.
According to a report by World
Health Organization (WHO) 2018, non-communicable diseases cause around 41
million deaths each year, which is equivalent to 71% of all deaths globally.
Also, cardiovascular diseases account for 17.9 million deaths each year,
followed by other respiratory diseases (3.9 million), diabetes (1.6 million),
and cancer (9.0 million) respectively. Such increasing prevalence of non-
communicable diseases boosts demand for quicker blood stream treatment, which
in turn is expected to significantly propel growth of the blood irradiation
market.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/blood-irradiation-market-1939
Infections in the blood stream
are diagnosed and irradiated by laser irradiation therapies. Increasing use of
such therapies is driving manufacturers to develop innovative blood irradiation
systems for improved health treatments, which is directly boosting the market
growth. For instance, in 2017 thriveMD, a U.S.-based company, introduced
ultraviolet blood irradiation (UVB) therapy, which is a photo-oxidation
treatment that briefly exposes a sample of the blood to ultraviolet light.
However, regulatory policies
regarding the medical systems and lack of skilled professionals in emerging
economies are likely to hamper the market growth. For instance, The Center for
Biologics Evaluation and Research (CBER) regulates the collection of blood and
blood components used for transfusion, CBER develops and enforces quality
standards, inspects blood establishments and monitors reports of errors,
accidents and adverse clinical events.
Global Blood Irradiation Market –
Competitive Landscape
Major players operating in the
global blood irradiation market include Typenex Medical, UVLrx Therapeutics,
Best Theratronics, Hitachi Medical Systems, Actemium NDT-PES, Rad Source
Technologies, and Gilardoni S.p.A. Market players are engaged in adopting
strategies such as mergers, collaborations, new product launches, and
partnerships to retain their position in the market. For instance, in 2017
Typenex Medical exclusively partnered with a European manufacturer- On Point Indicators
GmbH, to offer its product to customers.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1939
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment